Long-term Effectiveness and Safety in Hepatitis-co-infected Patients

Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China

NCT01074931 ·Status: COMPLETED

Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection

NCT01328158 ·Status: COMPLETED

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

NCT00234910 ·Status: COMPLETED ·Phase: PHASE3

Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients

NCT00116636 ·Status: COMPLETED ·Phase: PHASE2

A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects

NCT00121017 ·Status: WITHDRAWN ·Phase: PHASE2

Kaletra: Therapy With Double Protease Inhibitors

NCT01075191 ·Status: COMPLETED

A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation

NCT04138199 ·Status: TERMINATED

High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

NCT00247143 ·Status: UNKNOWN ·Phase: NA

GW873140 In Combination With Kaletra In HIV Infected Subjects

NCT00102778 ·Status: TERMINATED ·Phase: PHASE2

Special Investigation of Kaletra in Pregnant Women

NCT01076985 ·Status: COMPLETED

Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use

NCT01379703 ·Status: COMPLETED

Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet

NCT01097655 ·Status: COMPLETED

Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy

NCT00234962 ·Status: TERMINATED ·Phase: PHASE4

A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects

NCT00075231 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients

NCT00648999 ·Status: COMPLETED ·Phase: PHASE4

Surveillance of Kaletra in Korean Patients

NCT01083173 ·Status: COMPLETED

Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV Patients

NCT00661349 ·Status: TERMINATED ·Phase: PHASE4

Kaletra in Combination With Antiretroviral Agents

NCT01076179 ·Status: COMPLETED

Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients

NCT00752037 ·Status: COMPLETED ·Phase: PHASE4

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

NCT00866021 ·Status: COMPLETED ·Phase: PHASE4

Safety Study of Raltegravir in HIV/HCV Co-infected Patients

NCT01225705 ·Status: WITHDRAWN ·Phase: PHASE4

Kaletra-isentress Treatment Evaluation

NCT00700115 ·Status: COMPLETED ·Phase: PHASE4

Induction-maintenance of Lopinavir/r in HIV-infected Subjects

NCT00159224 ·Status: COMPLETED ·Phase: PHASE4

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

NCT00038519 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients

NCT00140751 ·Status: COMPLETED ·Phase: PHASE3